Haisco Pharmaceutical Group Co., Ltd.
002653
Clasificación en acciones
#2013
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
Precio por acción
$9.03
Capitalización bursátil
$10.30B
Cambio (1 día)
4.55%
Cambio (1 año)
24.15%
País
CN
Comercio Haisco Pharmaceutical Group Co., Ltd. (002653)
Categoría
Healthcare
Ratio P/B de Haisco Pharmaceutical Group Co., Ltd. (002653)
Ratio P/B al October 2026 TTM: 12.97
Según los informes financieros más recientes y el precio de las acciones de Haisco Pharmaceutical Group Co., Ltd., el ratio P/B actual (TTM) es 12.97. Al final de 2023, el ratio P/B era 6.30.
Historial del ratio P/B de Haisco Pharmaceutical Group Co., Ltd. desde 2008 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | 12.97 | 46.74% |
| 2024 | 8.84 | 40.24% |
| 2023 | 6.30 | -20.06% |
| 2022 | 7.88 | 2.00% |
| 2021 | 7.73 | 19.70% |
| 2020 | 6.46 | -29.69% |
| 2019 | 9.18 | 53.03% |
| 2018 | 6.00 | 4.90% |
| 2017 | 5.72 | -22.51% |
| 2016 | 7.38 | -31.60% |
| 2015 | 10.79 | 23.70% |
| 2014 | 8.72 | -21.38% |
| 2013 | 11.10 | 72.12% |
| 2012 | 6.45 | -27.45% |
| 2011 | 8.89 | -39.72% |
| 2010 | 14.74 | -68.96% |
| 2009 | 47.50 | 59.68% |
| 2008 | 29.74 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| 6.251 | -51.81% |
US
|
|
| 13.2547 | 2.18% |
US
|
|
| 4.208 | -67.56% |
AU
|
|
| 6.1824 | -52.34% |
NL
|
|
| - | - |
CH
|
